FindTrial
Sign In

Prognostic value of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography after autologous hematopoietic stem cell transplantation in lymphoma using Deauville scores

Prognostic value of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography after autologous hematopoietic stem cell transplantation in lymphoma using Deauville scores

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100042745
Enrollment
Unknown
Registered
2021-01-27
Start date
2021-02-01
Completion date
Unknown
Last updated
2021-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lymphoma

Interventions

Gold Standard:Pathological diagnosis
Index test:18F-FDG PET-CT

Sponsors

The First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 70 Years

Inclusion criteria

Inclusion criteria: All histologic types of NHL were allowed as well as HL, ASCT between January 2010 and December 2019 at the First Affiliated Hospital of Soochow University, and 18F-FDG PET/CT within 6 months after ASCT in our institution.

Exclusion criteria

Exclusion criteria: patients who were lost to follow-up within 6 months after ASCT

Design outcomes

Primary

MeasureTime frame
PFS;OS;—

Countries

China

Contacts

Public ContactNa Dai

The First Affiliated Hospital of Soochow University

dnsundaysong@163.com+86 13771793585

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026